BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4214868)

  • 1. Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.
    Kitamura H; Inai S
    J Immunol; 1974 Dec; 113(6):1992-2003. PubMed ID: 4214868
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G; Opferkuch W
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9.
    Rommel FA; Mayer MM
    J Immunol; 1973 Mar; 110(3):637-47. PubMed ID: 4688916
    [No Abstract]   [Full Text] [Related]  

  • 4. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 6. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8.
    Kolb WP; Müller-Eberhard HJ
    J Immunol; 1974 Aug; 113(2):479-88. PubMed ID: 4858623
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement: a reversible temperature-dependent alteration in the reactivity of EAC1 with C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):200-11. PubMed ID: 4197334
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A; Moriyama T; Inoue K; Inai S
    J Immunol; 1988 Apr; 140(7):2317-21. PubMed ID: 3351301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
    Goldlust MB; Shin HS; Hammer CH; Mayer MM
    J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement: optimal reaction conditions for guinea pig C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):189-99. PubMed ID: 4197333
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement dependent hemolysis of sheep erythrocytes coupled with non-antibody human IgG.
    Inai S; Tsuyuguchi I
    Biken J; 1968 Dec; 11(4):261-7. PubMed ID: 4181155
    [No Abstract]   [Full Text] [Related]  

  • 14. The functional size of the primary complement lesion in resealed erythrocyte membrane ghosts.
    Giavedoni EB; Chow YM; Dalmasso AP
    J Immunol; 1979 Jan; 122(1):240-5. PubMed ID: 570203
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of the classic and alternate complement pathways by endotoxin.
    Fine DP
    J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
    [No Abstract]   [Full Text] [Related]  

  • 16. Extraction of complement inhibitory factors from the erythrocytes of non-human species.
    Hoffmann EM; Etlinger HM
    J Immunol; 1973 Sep; 111(3):946-51. PubMed ID: 4741303
    [No Abstract]   [Full Text] [Related]  

  • 17. Independent and consecutive action of C5, C6 and C7 in immune hemolysis. II. Formation and decay of the intermediate complexes EAC1-5 and EAC1-6.
    Hadding U; Bitter-Suermann D; Wellensiek HJ
    Immunochemistry; 1970 Dec; 7(12):967-76. PubMed ID: 5503628
    [No Abstract]   [Full Text] [Related]  

  • 18. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemolytic assay of bovine serum complement.
    Barta O; Barta V
    J Immunol Methods; 1972 Aug; 1(4):363-74. PubMed ID: 4218251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.